Special PET scan for kidney cancer recurrence
Part of Cancer, Kidney & urinary, Women’s health & pregnancy clinical trials.
This trial uses a special PET scan to see if kidney cancer remains or has come back after treatment. The scan helps doctors find cancer cells more precisely, which may guide better treatment decisions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You must be able to understand and follow the study rules.
- If you are a woman who could become pregnant, you need a negative pregnancy test before the scan and agree to use two forms of birth control for at least 6 weeks after.
- You must have had a biopsy or imaging test (like a CT scan) within the last 3 months showing possible kidney cancer.
- You cannot be pregnant or breastfeeding.
- Your kidney function must be adequate (not severely reduced).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a special PET scan that may help doctors see if a complex kidney cyst is cancerous before surgery. It is for people who are already scheduled to have surgery to remove a kidney mass.
This study tests a new imaging agent that may help doctors see kidney cancer and certain other tumors more clearly on PET/CT scans. It could help find cancer that has spread or come back after treatment.
This trial tests a new imaging agent (68Ga-NYM096) that may help doctors see whether a kidney mass is cancer before surgery. By undergoing a PET/CT scan with this agent, you might help doctors better plan your surgery and avoid unnecessary procedures.
This trial tests a special PET scan to see if it can better find leftover kidney cancer after surgery compared to a standard CT scan. You may qualify if you had kidney cancer surgery within the last 4-16 weeks and are at high risk of the cancer coming back.
This study tests a new type of PET scan that uses a tracer called 68Ga-RCCB6 to see kidney cancer more clearly. It compares this scan to another PET scan (68Ga-PSMA) to help doctors stage the cancer, check treatment response, and detect any return of the disease.
This trial tests a new PET/CT scan that uses a special tracer to find clear cell kidney cancer. If you are scheduled for kidney tumor removal, this scan may help your surgeon see the cancer more clearly before surgery.
Hear when a new ccRCC trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.